Biotech Values

[biotech jim]

Viberzi (eluxadoline)

"We are very pleased to be working with the FDA to advance this IBS-D treatment and we eagerly await DEA scheduling determination later this year." My bolding.

http://www.prnewswire.com/news-releases/actavis-receives-fda-approval-for-viberzi-eluxadoline-for-the-treatment-of-irritable-bowel-syndrome-with-diarrhea-ibs-d-in-adults-300089793.html